Posted: August 6, 2015 Benefiting from the MMRF Pipeline
Andrea Rosengarden, wife and mother, recently celebrated a few important family milestones, including two college graduations and a beautiful wedding. Her...READ MORE
Posted: July 30, 2015 Advances in Minimal Residual Disease Testing in Myeloma Meeting
On July 10 in NYC, the MMRF helped host the “Advances in Minimal Residual Disease Testing in Multiple Myeloma” meeting at Memorial Sloan Kettering Cancer...READ MORE
Posted: July 28, 2015 FDA APPROVES KYPROLIS® (CARFILZOMIB) FOR COMBINATION USE IN THE TREATMENT OF...
THOUSAND OAKS, Calif. (July 24, 2015) – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New...READ MORE
Posted: July 28, 2015 Collaborating Toward a Cure
We’ve seen how dramatically patients’ lives can change when they are matched with the right treatment at the right time in their disease course. Although...READ MORE
Posted: June 29, 2015 Immunotherapy: Helping the Immune System Identify and Fight Cancer
Cancer cells, compared to foreign invaders, are more difficult for the immune system to identify and recognize as toxic because they originate from an...READ MORE
Posted: June 22, 2015 Immunotherapy: Boosting the Immune ResponseREAD MORE
Posted: June 18, 2015 Weekly Carfilzomib with Dexamethasone for patients with relapsed or refractory...
James Berenson , Alan Cartmell , Roger M. Lyons , Wael Harb , Dimitrios Tzachanis , Ralph Boccia , Robert M. Rifkin , Priti Patel , Sandra Dixon , Jesus BerdejaREAD MORE
Posted: June 18, 2015 Phase I/II Study Of The Combination Of Panobinostat And Carfilzomib In Patients...
Jesus G. Berdeja, Lowell L. Hart, Joseph R. Mace, Edward R. Arrowsmith, James H. Essell, Rami S. Owera, John D. Hainsworth, Ian W. FlinnREAD MORE
Posted: June 18, 2015 Effect of carfilzomib, lenalidomide, and dexamethasone (KRd) vs lenalidomide...
Meletios A. Dimopoulos, A. Keith Stewart, S. Vincent Rajkumar, Tamás Masszi, Albert Oriol, Roman Hajek, Laura Rosinol, David Samuel DiCapua Siegel, Georgi...READ MORE
Posted: June 18, 2015 Phase I interim safety and efficacy of venetoclax (ABT-199/GDC-0199)...
Shaji Kumar, Ravi Vij, Jonathan L. Kaufman, Joseph Mikhael, Thierry Facon, Philippe Moreau, Martine Amiot, Stefanie Alzate, Lura J Morris, Jeremy A Ross,...READ MORE